Biblio Discovery — Demo Discovery Service

46 results for "Patrick Lefebvre"

Showing 1–20 · 0.63 seconds · RSS

  1. Journal Article

    The contribution of teledentistry in detecting tooth erosion in patients with eating disorders

    Nicolas Giraudeau; Paul Camman; Laurence Pourreyron et al.

    Digital Health, Vol. 7 · 2021 · English · DOAJ Scopus

    Objective The aim of this study was to demonstrate that including a teledentistry consultation in the standard care provided to patients in an eating disorder day hospital could be beneficial, notably for screening for particular pathologies and preventing dental erosion. Methods We included 50…

  2. Journal Article

    Adherence, healthcare resource utilization and Medicaid spending associated with once-monthly paliperidone palmitate versus oral atypical antipsychotic treatment among adults recently diagnosed with schizophrenia

    Dominic Pilon; Erik Muser; Patrick Lefebvre et al.

    BMC Psychiatry, Vol. 17 No. 1 · 2017 · English · DOAJ Scopus

    Abstract Background Once-monthly paliperidone palmitate (PP1M) is a long-acting injectable antipsychotic that may increase adherence rates, reduce hospitalizations, and lower medical costs compared to oral atypical antipsychotics (OAAs) among schizophrenia patients. However, the impact of PP1M in…

  3. Journal Article Full text

    Adherence to rivaroxaban versus apixaban among patients with non-valvular atrial fibrillation: Analysis of overall population and subgroups of prior oral anticoagulant users

    Colleen A. McHorney; Concetta Crivera; François Laliberté et al.

    PLOS ONE, Vol. 13 No. 4 · 2018 · English · PLOS Scopus

    Background: Medication non-adherence can result in poor health outcomes. Understanding differences in adherence rates to non-vitamin K oral anticoagulants (NOACs) could guide treatment decisions and improve clinical outcomes among patients with non-valvular atrial fibrillation (NVAF). Objective: To…

    Also available at: DOAJ

  4. Journal Article Full text

    Real-World Analysis of Weight Gain and Body Mass Index Increase Among Patients with HIV-1 Using Antiretroviral Regimen Containing Tenofovir Alafenamide, Tenofovir Disoproxil Fumarate, or Neither in the United States

    Bruno Emond; Carmine Rossi; Rachel Rogers et al.

    Journal of Health Economics and Outcomes Research (2022) · 2022 · English · DOAJ Scopus

    **Background:** While some studies among patients with HIV-1 suggest that antiretroviral therapy (ART) regimens containing tenofovir alafenamide (TAF) may be associated with greater weight gain than those not containing TAF, no studies have assessed the relationship between TAF doses and weight…

    Also available at: DOAJ

  5. Journal Article

    Long-Term Psoriasis Control with Guselkumab, Adalimumab, Secukinumab, or Ixekizumab in the USA

    Timothy Fitzgerald; Maryia Zhdanava; Dominic Pilon et al.

    Dermatology and Therapy, Vol. 13 No. 4 · 2023 · English · DOAJ Scopus

    Abstract Background Biologics have revolutionized the management of psoriasis, but response to treatment varies. Loss of treatment efficacy may occur over time, requiring treatment switching or escalation. Claims data on persistence may be informative of real-world treatment outcome. This analysis…

  6. Journal Article

    A Cross-Sectional Study of Patient Out-of-Pocket Costs for Antipsychotics Among Medicaid Beneficiaries with Schizophrenia

    Dee Lin; Dominic Pilon; Laura Morrison et al.

    Drugs - Real World Outcomes, Vol. 10 No. 3 · 2023 · English · DOAJ Scopus

    Abstract Background Patient affordability is an important nonclinical consideration for treatment access among patients with schizophrenia. Objective This study evaluated and measured out-of-pocket (OOP) costs for antipsychotics (APs) among Medicaid beneficiaries with schizophrenia. Methods Adults…

  7. Journal Article Full text

    Burden of treatment-resistant depression in Medicare: A retrospective claims database analysis

    Dominic Pilon; Kruti Joshi; John J. Sheehan et al.

    PLOS ONE, Vol. 14 No. 10 · 2019 · English · PLOS Scopus

    Background: Previous studies have assessed the incremental economic burden of treatment-resistant depression (TRD) versus non-treatment-resistant major depressive disorder (i.e., non-TRD MDD) in commercially-insured and Medicaid-insured patients, but none have focused on Medicare-insured patients…

    Also available at: DOAJ

  8. Journal Article Full text

    Correction: Burden of treatment-resistant depression in Medicare: A retrospective claims database analysis

    Dominic Pilon; Kruti Joshi; John J. Sheehan et al.

    PLOS ONE, Vol. 16 No. 4 · 2021 · English · PLOS Scopus

    [This corrects the article DOI: 10.1371/journal.pone.0223255.].

    Also available at: DOAJ

  9. Journal Article Full text

    Weight Change and Predictors of Weight Change Among Patients Initiated on Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide or Bictegravir/Emtricitabine/Tenofovir Alafenamide: A Real-World Retrospective Study

    Bruno Emond; Carmine Rossi; Aurélie Côté-Sergent et al.

    Journal of Health Economics and Outcomes Research, Vol. 8 No. 1 · 2021 · English · DOAJ Scopus

    # Background Recent evidence suggests that integrase strand transfer inhibitors are associated with greater weight gain than protease inhibitors in patients with human immunodeficiency virus (HIV-1). # Objectives To describe demographic and clinical characteristics of insured patients with HIV-1 in…

    Also available at: DOAJ

  10. Journal Article

    Epidemiology and patient journey of Rett syndrome in the United States: a real-world evidence study

    Damian May; Kalé Kponee-Shovein; Malena Mahendran et al.

    BMC Neurology, Vol. 23 No. 1 · 2023 · English · DOAJ Scopus

    Abstract Background Rett syndrome (RTT) is a neurodevelopmental disorder that almost exclusively affects females and is associated with high clinical burden. However, literature characterizing the real-world journey of patients with RTT is limited. This study provided an overview of the…

  11. Journal Article

    Real-World Clinical Outcomes and Treatment Patterns Among Black and Non-Black Patients With Prostate Cancer Initiated on Apalutamide in a Urology Setting

    Benjamin H. Lowentritt; Carmine Rossi; Erik Muser et al.

    Journal of Health Economics and Outcomes Research, Vol. 11 No. 2 · 2024 · English · DOAJ Scopus

    # Background The use of androgen receptor signaling inhibitors, including apalutamide, in combination with androgen deprivation therapy is recommended for the treatment of metastatic castration-sensitive prostate cancer (mCSPC) and non-metastatic castration-resistant prostate cancer (nmCRPC). #…

  12. Journal Article

    Predictors of frontline doublet or triplet regimen initiation in transplant-ineligible newly diagnosed multiple myeloma

    Matthew J. Pianko; Niodita Gupta-Werner; Bruno Emond et al.

    Future Science OA, Vol. 11 No. 1 · 2025 · English · DOAJ Scopus

    Aims To identify predictors for initiation of frontline doublet versus triplet therapy for transplant-ineligible newly diagnosed multiple myeloma.Materials and Methods Using Flatiron Health data, a random forest model was used to identify baseline predictors of frontline doublet or triplet…

  13. Journal Article

    Healthcare resource utilization and costs associated with inflammatory bowel disease among patients with chronic inflammatory diseases: a retrospective cohort study

    David P. Hudesman; Soumya D. Chakravarty; Bruno Emond et al.

    BMC Rheumatology, Vol. 4 No. 1 · 2020 · English · DOAJ Scopus

    Abstract Background Chronic inflammatory diseases (CIDs; ankylosing spondylitis [AS], psoriatic arthritis [PsA], psoriasis [PsO], or rheumatoid arthritis [RA]) and inflammatory bowel disease (IBD; Crohn’s disease and ulcerative colitis) are associated with substantial economic burden. The relative…